Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations

01 May 2023

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Tarricone et al. reviewed the new EU regulations for medical devices and health technology assessment, highlighting their potential benefits in increasing clinical evidence quality and reducing fragmentation in the EU market access process. The authors also provided recommendations for the structure of a potential new Accelerated Access Pathway for innovative, high-risk (in particular implantable and class III) medical devices which would fit the pan-European context and safely accelerate patient access.

Access the full-text article here.